Spotlight on Epigenetics Drug Discovery

Efforts to unravel the epigenome and a deeper understanding of the role epigenetic pathways play in cell function and disease have led to intense drug-discovery initiatives both in academia and the pharma/biotech industry. The Scientist brings together a panel of experts to address some of the key questions that the field is grappling with today.

The Scientist Marketing Team
May 11, 2014

Efforts to unravel the epigenome and a deeper understanding of the role epigenetic pathways play in cell function and disease have led to intense drug-discovery initiatives both in academia and the pharma/biotech industry. The Scientist brings together a panel of experts to address some of the key questions that the field is grappling with today.

Epigenetics is drawing a lot of attention in recent years, driven by recent advances in science and technology. Efforts to unravel the epigenome and a deeper understanding of the role epigenetic pathways play in cell function and disease have led to intense drug-discovery initiatives both in academia and the pharma/biotech industry. The Scientist brings together a panel of experts to address some of the key questions that the field is grappling with today. Attendees can interact with the expert panelists during the live webinar by asking pertinent questions and sharing their experiences in epigenetics research.

Topics To Be Covered:

  • Do we have a good understanding of the mechanisms underlying epigenetics?
  • Do we have the right in vitro assays, screening platforms, and in vivo models?
  • How do we tackle the concerns about safety and adverse events?
  • Case studies highlighting current challenges and opportunities

View The Video Now

Meet the Speakers:

Dr....

 

 

Dr. Jatinder Singh
Principal Scientist, Drug Safety and Metabolism
AstraZeneca Pharmaceuticals (speaking independently of AstraZeneca)


 

Rockland
Reaction
Cell Signaling

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?